SUBSTITUTIONEN AM RINGSYSTEM DER LYSERGSAURE .3. HALOGENIERUNG .45. MITTEILUNG UBER MUTTERKORNALKALOIDE

被引:52
作者
TROXLER, F
HOFMANN, A
机构
关键词
D O I
10.1002/hlca.19570400716
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:2160 / 2170
页数:11
相关论文
共 13 条
[1]  
BERDE B., 1956, HELVETICA PHYSIOL ET PHARMACOL ACTA, V14, P325
[2]   ROLE OF 5-HYDROXYTRYPTAMINE IN MENTAL DISEASES AND ITS ANTAGONISM TO LYSERGIC ACID DERIVATIVES [J].
CERLETTI, A ;
ROTHLIN, E .
NATURE, 1955, 176 (4486) :785-786
[3]  
CERLETTI A, 1956, ARCH EXP PATHOL PH, V228, P146
[4]  
POHM M., 1953, ARCH PHARM U BER DEUTSCH PHARM GES, V286, P509, DOI 10.1002/ardp.19532861009
[5]   ZUR KENNTNIS DES POLYPEPTIDTEILS DER MUTTERKORNALKALOIDE-II PARTIELLE ALKALISCHE HYDROLYSE DER MUTTERKORNALKALOIDE .20. UBER MUTTERKORNALKALOIDE [J].
STOLL, A ;
HOFMANN, A .
HELVETICA CHIMICA ACTA, 1950, 33 (06) :1705-1711
[6]  
SUMPTER WC, 1954, HETEROCYCLIC COMPOUN, P29
[7]  
TREIBS A, 1955, Z PHYSIOL CHEM, V299, P168
[8]  
VONDOBENECK H, 1955, Z PHYSL CHEM, V299, P214
[9]  
ZEHNDER K., 1956, HELVETICA PHYSIOL ET PHARMACOL ACTA, V14, P264
[10]  
1957, Patent No. 263279